The Fondation Arthritis is the leading source of private funding to support the emergence of high-quality research into rheumatism and musculoskeletal disorders (MSDs). It funds research into the causes and consequences of these diseases, which can be disabling for adults and children alike. It encourages the discovery of innovative therapies.
Rheumatic and musculoskeletal disorders include over 200 different pathologies. They affect 20% of the population at all ages. A private organisation serving the public interest has been at the heart of research for over 30 years : the Fondation Arthritis.
Chairman of the Fondation Arthritis
DR Olivier Courtin-Clarins
“The Arthritis Foundation is devotedto ambitions that have always motivated me. I know a lot about bones and joints. My career as an orthopaedic surgeon and my fascination with science take concrete form in the Foundation’s initiatives. My ambitions are clear: helping to heal chronic inflammatory rheumatism, working to promote the osteoarticular field as a whole, creating lasting links between different fields within rheumatology to boost innovation, and raising awareness of the reality of these terribly disabling diseases, which affect patients of all ages, and even the very young.“
Msds, Everyone is affected
Rheumatic and musculoskeletal disorders (MSDs) constitute a group of over 200 illnesses and syndromes that mostly affect the joints but also the bones, internal organs, muscles and associated tissues such as tendons and ligaments. MSDs can start in childhood or early adulthood, meaning that patients often have to endure these conditions for decades, leading to a gradual decline in their psychological and physical state and to social isolation.
The impact seen with certain chronic MSDs is accentuated with ageing, as well as certain aggravating lifestyle factors such as obesity and reduced physical activity.
The Foundation makes a concerted effort to support translational research. This research aims to accelerate the process of converting the core data gathered into clinical evidence. The Foundation offers support to mixed teams of researchers and clinicians, to promote innovative projects, both to develop new diagnostic tools and to discover new treatments for MSDs.
The clinical aspect of the research is also supported by encouragement to develop epidemiological studies or innovative clinical trials.
Seeing Patients As Individuals
In line with its new slogan “Impact for patients”, the Foundation aims to support more innovative research that will quickly translate into benefits for patients. This will involve combining scientific excellence with more determined consideration for the unmet needs of patients with MSDs.
100% of donations collected from the public go to research
Thanks to the whole Courtin family and the backing of the Clarins company, all donations from the public are dedicated to fulfilling the Foundation’s mission. The sponsorship in kind from Clarins includes accommodation, postage, IT, voluntary work from many employees and operating expenses (including the salaries of the permanent staff).
The Fondation Arthritis’ Ambition For 2030:
Curing Rheumatoid Arthritis
Significantly Reducing Joint Pain For All Msds
Uniting The Players In The Foundation’s Ecosystem As Committed Influencers
By becoming a donor, you contribute to the progress of research by providing funding, benefits in kind or skills. Now let’s come together in our millions to achieve our goal: a cure!